Insider filing · RAPP
Rapport Therapeutics, Inc.
RAPP · Healthcare · 38 filings in 24 months
ticker →
Third Rock Ventures V, L.P. sold $744K of Rapport Therapeutics (RAPP)
Executed May 26, disclosed May 28, 2 days later.
Value, as filed
$744K
18,572 sh × $40.05
Executed
May 26
the trade date, as filed
Disclosed
May 28
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TP
Third Rock Ventures V, L.P.
10% owner
profile →
Third Rock Ventures V, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $5.4M of RAPP (133,618 sh × $40.24, as filed), executed May 11.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Third Rock Ventures V, L.P. in RAPP
RAPPSALE
Rapport Therapeutics, Inc.
$5.4M133,618 sh × $40.24
Exec May 11
Filed May 13 · 5:30 PM ET